1. Home
  2. LARK vs KRRO Comparison

LARK vs KRRO Comparison

Compare LARK & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landmark Bancorp Inc.

LARK

Landmark Bancorp Inc.

HOLD

Current Price

$27.58

Market Cap

171.0M

Sector

Finance

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$10.39

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LARK
KRRO
Founded
1885
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.0M
150.0M
IPO Year
2001
2019

Fundamental Metrics

Financial Performance
Metric
LARK
KRRO
Price
$27.58
$10.39
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$34.80
AVG Volume (30 Days)
3.5K
72.9K
Earning Date
04-29-2026
05-13-2026
Dividend Yield
3.07%
N/A
EPS Growth
35.84
N/A
EPS
0.83
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$33.46
N/A
Revenue Growth
N/A
181.46
52 Week Low
$23.43
$5.20
52 Week High
$30.80
$55.89

Technical Indicators

Market Signals
Indicator
LARK
KRRO
Relative Strength Index (RSI) 51.32 32.63
Support Level $27.01 $9.90
Resistance Level $28.76 $14.52
Average True Range (ATR) 0.85 0.83
MACD -0.02 -0.33
Stochastic Oscillator 57.50 2.08

Price Performance

Historical Comparison
LARK
KRRO

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and Southwest Kansas.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: